Sandeep Laumas
CFO & Chief Business OfficerDr. Sandeep Laumas, also known as Steve, M. D., serves as an Independent Director at Unicycive Therapeutics, Inc. since 2018. Dr. Laumas served as a Director at Invea Therapeutics, Inc until May 2022. He has been Chief Financial Officer of Instil Bio, Inc. since February 2021 and Chief Business Officer since June 2020. He served as Director at 9 Meters Biopharma Inc. since January 29, 2018 until June 22, 2021. Previously, he served as the Executive Chairman of 9 Meters Biopharma Inc. from January 2014 to April 2020 and its Chief Executive Officer from February 2019 to April 2020. Dr. Laumas founded Bearing Circle Capital in August 2007 and has been its Chief Executive Officer and Managing Director since August 2007. Dr. Laumas has extensive experience investing in the healthcare industry. Dr. Laumas served as a Managing Director of North Sound Capital from 2003 to 2007. At North Sound, Dr. Laumas was responsible for the global healthcare investment portfolio, working with a team of in-house Analysts and multiple consultants. Dr. Laumas has been a Director of Globavir Biosciences, Incorporated since 2015. Dr. Laumas started his career at Goldman Sachs & Co. in 1996 as an equity Analyst in the Healthcare Investment Banking Division and served in that role until 2000 working on mergers and acquisitions and corporate finance transactions and then transitioned to the Healthcare Equity Research Division within it. He served as a Director of BioXcel Corporation from May 2013 to August 2017. Dr. Laumas left Goldman Sachs and transitioned to the buy side at Balyasny Asset Management in 2001. In August 2007, Dr. Laumas founded Bearing Circle Capital, LP, an investment Partnership and has served as its Managing Director since such time. Dr. Laumas also served as Analyst at Balyasny Asset Management from 2001 to 2003. Dr. Laumas was a Co-Founder of MMP Systems from 2000 to 2001. Dr. Laumas serves as Director of Bearing Circle Capital. Dr. Laumas had been an Independent Director of BioXcel Therapeutics, Inc. since September 2017 until September 20, 2023 and serves as its Director. Dr. Laumas was a Non-Executive Director of Agilus Diagnostics Limited since February 4, 2011 to 2012. Dr. Laumas served as Director of Polarismed Capital. Dr. Laumas served as a Non-Executive Director of Parkway Holdings Ltd. from May 12, 2010 to August 2010. Dr. Laumas had received his A. B. in chemistry from Cornell University in 1990, M. D. from Albany Medical College in 1995 with a research gap year at the Dana-Farber Cancer Institute and completed his medical internship at the Yale University School of Medicine in 1996.
Positions
- Company NameInstil Bio, Inc.Stock CodeTILPositionCFO & Chief Business Officer
- Company NameBioXcel Therapeutics, Inc.Stock CodeBTAIQPositionIndependent DirectorColleagues
- VDVimal D. MehtaFounder & Director
- PRPeter R. MuellerIndependent Chairman & Lead Director
- SSSamir SaleemPresident, Secretary, Principal Executive Officer & Chief Restructuring Officer
- MHMark H. PavaoActing Chief Commercial Officer
- MMMatt MandelVice President of Clinical Development
- SLSandeep LaumasIndependent Director
- SMSteven M. PaulMember of Advisory Board
- SKSheila K. GujrathiMember of Advisory Board
- Company NameUnicycive Therapeutics, Inc.Stock CodeUNCYPositionIndependent DirectorColleagues
- SKShalabh K. GuptaFounder, Chairman, CEO & President
- PGPramod GuptaExecutive Vice President of Pharmaceutical and Business Operations
- DJDouglas JermasekExecutive Vice President of Corporate Strategy
- JWJohn W. TownsendChief Financial Officer
- SKSaraswati Kenkare-MitraIndependent Director
- MSMeredith S. ManningIndependent Director
- RLRavindra L. MehtaMember of Scientific Advisory Board
